The Silent Departure: Hagerty’s Insider Sales and the SPAC Paradox

Insider selling within publicly traded companies is like a silent storm, often unnoticed until its effects are felt. One recent example is Hagerty, Inc. (HGTY), an insurer backed by a Special Purpose Acquisition Company (SPAC) and renowned for its vintage car valuation tools. The departure of the company’s biggest insider, director Robert I. Kauffman, as he slowly unloads his shares, has raised doubts about the implications of such divestitures in the post-SPAC landscape. While these activities are within the bounds of legality as per Rule 10b5-1 trading plan, they invite inquiries about how they are viewed by the market, investors, and the enduring aftermath of the SPAC era’s underperformance.

Kauffman, who owns approximately 3.56% of Hagerty, has sold over 1.38 million shares since January 2025, pocketing close to $14.3 million. These sales are part of a pre-arranged trading strategy through his company Aldel LLC, intended to prevent accusations of manipulating the market. However, the sheer scale of these transactions is notable since they represent about 2% of his total shares. The timing is also significant, considering that Hagerty’s shares have mostly fluctuated between $9.00 and $12.00 since mid-2024, a phase marked by skepticism towards SPACs in general. Kauffman’s sales, although not explicitly negative, align with an industry trend of insider sells during a decline in stock value post-merger.

SPACs were initially deemed as a new approach for companies to enter the public market, but they have earned a reputation for allowing insiders to extract wealth. Sponsors typically receive 20% of the target company post-merger, which incentivizes them to sell their shares once lock-up periods expire. Hagerty’s scenario reflects this pattern: Kauffman’s trading plan enables him to cash in his shares without overtly displaying pessimism, but the market interprets it as a lack of belief in the company’s future.

Despite these challenges, Hagerty’s underlying business remains robust. With its main products being vehicle valuation tools and insurance, the company has a steady revenue flow and a loyal customer base. Its recent expansion into electric vehicle (EV) valuation tools has positioned it for further growth, even in the face of headwinds in the wider auto insurance industry. However, the ongoing insider selling adds complexity to the narrative. While Kauffman’s retained shares indicate a continued alignment with shareholders, the accumulation of his sales—especially in a market wary of SPAC-related issues—could affect investor confidence.

Investors contemplating involvement with Hagerty must consider several factors. The company’s relatively small float could result in heightened volatility with any insider selling, even if the motive is not bearish. If Hagerty can showcase consistent EBITDA growth and bolster its EV offerings, it might break free from the negative associations linked with SPACs. The success of Hagerty’s strategy will rely on how the market interprets internal sales—whether as routine business or opportunistic maneuvers.

Hagerty’s internal selling is emblematic of the dilemmas posed by the SPAC landscape—legally permissible, strategically neutral, but potentially damaging psychologically. Investors should realize that not all SPACs are alike and should be vigilant of the combination of internal behavior and operational performance. In an atmosphere where perception often carries more weight than reality, the subtle departure of stakes by key players can hold significant importance. Investors should view Hagerty through a dual lens: appraise its ability to execute its growth objectives and monitor internal activities as indicators of trust. Navigating the fine line between liquidity and skepticism is crucial in the SPAC era, and those who understand this balance will be in the best position to reap the rewards.